Search Results | American Association for Cancer Research

1-20 of 178

2 3 4 5

Sort by

Sort Order Select

Journal Articles

CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease

Clin Cancer Res clincanres.3858.2021-11-1 14:03:07.837.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3858

Published: 23 May 2022

View article

Includes: Supplementary data

Journal Articles

A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance

Christina Mark, Jay Warrick, Natalie S. Callander, Peiman Hematti, Shigeki Miyamoto

Mol Cancer Res molcanres.0941.2021.

DOI: https://doi.org/10.1158/1541-7786.MCR-21-0941

Published: 23 May 2022

View article

Includes: Supplementary data

Journal Articles

Circulating tumor DNA-based MRD assessment in patients with CLL treated with obinutuzumab, acalabrutinib and venetoclax

Moritz Fürstenau, Jonathan Weiss, Adam Giza, Fabian Franzen, Sandra Robrecht, Anna-Maria Fink, Kirsten Fischer, Christof Schneider, Eugen Tausch, Stephan Stilgenbauer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Barbara Eichhorst, Michael Hallek, Paula Cramer

Clin Cancer Res clincanres.0433.2022-2-8 15:40:23.327.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0433

Published: 20 May 2022

View article

Includes: Supplementary data

Journal Articles

Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study

Manuel Weber, David Kersting, Burkhard Riemann, Tim Brandenburg, Dagmar Führer-Sakel, Frank Grünwald, Michael C. Kreissl, Henning Dralle, Frank Weber, Kurt Werner. Schmid, Ken Herrmann, Walter Jentzen, Hong Grafe, Christoph Rischpler, Sarah Theurer, Andreas Bockisch, James Nagarajah, Wolfgang P. Fendler

Clin Cancer Res clincanres.0437.2022-2-9 05:28:38.980.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0437

Published: 20 May 2022

View article

Includes: Supplementary data

Journal Articles

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma

Clin Cancer Res OF1–OF15.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4053

Published: 20 May 2022

View article

Includes: Supplementary data

Journal Articles

Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multi-Omics Analysis

Cancer Immunol Res canimm.1101.2022-1-3 09:35:19.220.

DOI: https://doi.org/10.1158/2326-6066.CIR-21-1101

Published: 20 May 2022

View article

Includes: Supplementary data

Journal Articles

Systemic immune dysfunction in cancer patients driven by IL6 induction of LAG3 in peripheral CD8+ T cells

Ashwin Somasundaram, Anthony R. Cillo, Caleb Lampenfeld, Creg J. Workman, Sheryl Kunning, Lauren N. Oliveri, Maria Velez, Sonali Joyce, Michael Calderon, Rebekah Dadey, Dhivyaa Rajasundaram, Daniel P. Normolle, Simon C. Watkins, James G. Herman, John M. Kirkwood, Evan J. Lipson, Robert L. Ferris, Tullia C. Bruno, Dario A.A. Vignali

Cancer Immunol Res canimm.0736.2020.

DOI: https://doi.org/10.1158/2326-6066.CIR-20-0736

Published: 19 May 2022

View article

Includes: Supplementary data

Journal Articles

P2RX7 enhances tumor control by CD8+ T cells in adoptive cell therapy.

Kelsey M. Wanhainen, Changwei Peng, Maggie H. Zhou, Bruna de Gois Macedo, Stephen O'Flanagan, Tingyuan Yang, Ameeta Kelekar, Brandon J. Burbach, Henrique Borges da Silva, Stephen C. Jameson

Cancer Immunol Res canimm.0691.2021.

DOI: https://doi.org/10.1158/2326-6066.CIR-21-0691

Published: 19 May 2022

View article

Includes: Supplementary data

Journal Articles

GAS6-AXL inhibition by AVB-500 overcomes resistance to paclitaxel in endometrial cancer by decreasing tumor cell glycolysis

Shaina F. Bruce, Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt, Barbara Blachut, Mary M. Mullen, Lindsay M. Kuroki, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Dineo Khabele, Matthew A. Powell, David G. Mutch, Leah P. Shriver, Gary J. Patti, Katherine C. Fuh

Mol Cancer Ther molcanther.0704.2021.

DOI: https://doi.org/10.1158/1535-7163.MCT-21-0704

Published: 19 May 2022

View article

Includes: Supplementary data

Journal Articles

Mapping the Lay of the Land: Using Interactive Network Analytic Tools for Collaboration in Rural Cancer Prevention and Control

Bobbi J. Carothers, Peg Allen, Callie Walsh-Bailey, Dixie Duncan, Rebeca Vanderburg Pacheco, Karen R. White, Debra Jeckstadt, Edward Tsai, Ross C. Brownson

Cancer Epidemiol Biomarkers Prev OF1–OF9.

DOI: https://doi.org/10.1158/1055-9965.EPI-21-1446

Published: 19 May 2022

View article

Includes: Supplementary data

Journal Articles

Targeting DUSP activity as a treatment for high grade serous ovarian carcinoma

Brooke E. Sanders, Tomomi M. Yamamoto, Alexandra McMellen, Elizabeth R. Woodruff, Amber Berning, Miriam D. Post, Benjamin G. Bitler

Mol Cancer Ther molcanther.0682.2021.

DOI: https://doi.org/10.1158/1535-7163.MCT-21-0682

Published: 19 May 2022

View article

Includes: Supplementary data

Journal Articles

Multiphoton phosphorescence quenching microscopy reveals kinetics of tumor oxygenation during anti-angiogenesis and angiotensin signaling inhibition

John D. Martin, Ryan M. Lanning, Vikash P. Chauhan, Margaret R. Martin, Ahmed S. Mousa, Walid S. Kamoun, Hee-Sun Han, Hang Lee, Triantafyllos Stylianopoulos, Moungi G. Bawendi, Dan G. Duda, Edward B. Brown, Timothy P. Padera, Dai Fukumura, Rakesh K. Jain

Clin Cancer Res clincanres.0486.2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0486

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer

Cancer Res canres.CAN-21-2072-E.2021.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-2072

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Activity and resistance of a brain-permeable paradox breaker BRAF inhibitor in melanoma brain metastasis

Cancer Res canres.4152.2021.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-4152

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer

Dragana Kopanja, Vaibhav Chand, Eilidh Mills. O'Brien, Nishit K. Mukhopadhyay, Maria Paula. Zappia, Abul B.M.M.K. Islam, Maxim Frolov, Bradley J. Merrill, Pradip Raychaudhuri

Cancer Res canres.0410.2022.

DOI: https://doi.org/10.1158/0008-5472.CAN-22-0410

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL

Patrick R. Hagner, Hsiling Chiu, Vivek S. Chopra, Martino Colombo, Nisha Patel, Maria Ortiz Estevez, Michelle F. Waldman, Remco Loos, Fadi Towfic, Anita K. Gandhi

Clin Cancer Res clincanres.3347.2021.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3347

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Antagonist, with Nab-Paclitaxel in Solid Tumors

Pamela N. Munster, Andrew E. Greenstein, Gini F. Fleming, Erkut Borazanci, Manish R. Sharma, Joseph M. Custodio, Iulia Cristina Tudor, Hristina I. Pashova, Stacie Peacock Shepherd, Andreas Grauer, Jasgit C. Sachdev

Clin Cancer Res clincanres.4363.2021.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-4363

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients

Chiara Monfrini, Federico Stella, Vanessa Aragona, Martina Magni, Silva Ljevar, Cristina Vella, Eugenio Fardella, Annalisa Chiappella, Francesca Nanetti, Martina Pennisi, Anna Dodero, Anna Guidetti, Paolo Corradini, Cristiana Carniti

Clin Cancer Res clincanres.0164.2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0164

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

Phase II clinical trial of Eribulin-gemcitabine combination therapy in previously treated patients with advanced liposarcoma or leiomyosarcoma

Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Jee Hung Kim, Yoon Woo Koh, Inkyung Jung, Su-Jin Shin, Sun Young Rha, Jin-Hee Ahn, Hyo Song Kim

Clin Cancer Res clincanres.CCR-22-0518-E.2022.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0518

Published: 18 May 2022

View article

Includes: Supplementary data

Journal Articles

VERONICA: Randomized Phase 2 Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, Biomarker Results

Geoffrey J. Lindeman, Tharu M. Fernando, Rebecca Bowen, Katarzyna J. Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steven McCune, Anne Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R. Wilson, Aulde Flechais, Aditya Bardia

Clin Cancer Res clincanres.3811.2021.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3811

Published: 18 May 2022

View article

Includes: Supplementary data

2 3 4 5

NARROW

CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease

A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance

Circulating tumor DNA-based MRD assessment in patients with CLL treated with obinutuzumab, acalabrutinib and venetoclax

Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma

Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multi-Omics Analysis

Systemic immune dysfunction in cancer patients driven by IL6 induction of LAG3 in peripheral CD8+ T cells

P2RX7 enhances tumor control by CD8+ T cells in adoptive cell therapy.

GAS6-AXL inhibition by AVB-500 overcomes resistance to paclitaxel in endometrial cancer by decreasing tumor cell glycolysis

Mapping the Lay of the Land: Using Interactive Network Analytic Tools for Collaboration in Rural Cancer Prevention and Control

Targeting DUSP activity as a treatment for high grade serous ovarian carcinoma

Multiphoton phosphorescence quenching microscopy reveals kinetics of tumor oxygenation during anti-angiogenesis and angiotensin signaling inhibition

Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer

Activity and resistance of a brain-permeable paradox breaker BRAF inhibitor in melanoma brain metastasis

Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer

Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Antagonist, with Nab-Paclitaxel in Solid Tumors

Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients

Phase II clinical trial of Eribulin-gemcitabine combination therapy in previously treated patients with advanced liposarcoma or leiomyosarcoma

VERONICA: Randomized Phase 2 Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, Biomarker Results

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only